MRX Price Prediction Next Week
Analysis and Insights
Technical Analysis:
Marex Group plc (MRX) has shown a bullish trend with the price closing at $34.36 on March 24, 2025. The stock is trading above its 20-day SMA, indicating short-term bullish momentum. The RSI is at 45.17, suggesting the stock is in a neutral zone, not overbought or oversold. The MACD is slightly negative but showing signs of convergence, which could indicate a potential bullish crossover soon.
Fibonacci Levels:
The Fibonacci levels indicate resistance at $34.72 (R1) and $35.88 (R2), with support at $32.85 (S1). The price is currently testing the first resistance level, which could be a critical point for a breakout.
News Sentiment:
Marex Group was highlighted as a top value stock with strong earnings growth, making it attractive for investors seeking value. The company has a lower P/E ratio compared to its industry peers, which is a positive sign for investors.
Price Prediction:
Based on the technical indicators and news sentiment, the stock is expected to break above the first resistance level and reach $35.50 by the end of the next trading week.
Recommendation:
Buy Marex Group plc (MRX) as the stock is expected to rise to $35.50 next week, supported by positive news and bullish technical indicators.
MRX Similar Chart Price Prediction
The price of MRX is predicted to go up -1.15%, based on the high correlation periods with VSTA. The similarity of these two price pattern on the periods is 95.7%.
MRX
VSTA
Down: -1.15%Similarity: 95.7%
MRX Revenue Forecast
MRX EPS Forecast
MRX FAQs
What is MRX revenue forecast for next quarter？
What is MRX eps forecast for next quarter？
MRX Analyst's Forecast
Benjamin Budish
Barclays
Buy
2025-03-07
Price Target
$39 → $43
Upside
+18.2%
Barclays analyst Benjamin Budish raised the firm's price target on Marex Group to $43 from $39 and keeps an Overweight rating on the shares following the Q4 report. The company reported an earnings beat, driven by higher revenues across all businesses, the analyst tells investors in a research note.
Benjamin Budish
Barclays
Buy
2025-01-13
Price Target
$35 → $39
Upside
+24.48%
Patrick Moley
Piper Sandler
Buy
2025-01-07
Price Target
$32 → $40
Upside
+23.8%
